Michael Aagaard Andersen

Michael Aagaard Andersen

Assistant Professor

ORCID: 0000-0001-6097-2272

Publication year:
All
1 - 4 out of 4Page size: 10
  1. 2021
  2. Published

    Antimicrobial use before chronic lymphocytic leukemia: a retrospective cohort study

    Andersen, Michael Aagaard, Rostgaard, K., Niemann, Carsten & Hjalgrim, Henrik, 2021, In: Leukemia. 35, 3, p. 747-751 5 p.

    Research output: Contribution to journal › Journal article › peer-review

  3. 2019

  4. Long-Term Exposure to PFE-360 in the AAV-α-Synuclein Rat Model: Findings and Implications

    Andersen, Michael Aagaard, Sotty, F., Jensen, P. H., Badolo, L., Jeggo, R., Smith, G. P. & Christensen, K. V., 7 Nov 2019, In: eNeuro. 6, 6

    Research output: Contribution to journal › Journal article › peer-review

  5. 2018

  6. Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-α-synuclein is normalized by LRRK2 modulation

    Andersen, Michael Aagaard, Christensen, K. V., Badolo, L., Smith, G. P., Jeggo, R., Jensen, P. H., Andersen, K. J. & Sotty, F., Aug 2018, In: Neurobiology of Disease. 116, p. 13-27 15 p.

    Research output: Contribution to journal › Journal article › peer-review

  7. PFE-360-induced LRRK2 inhibition induces reversible, non-adverse renal changes in rats

    Andersen, Michael Aagaard, Wegener, K. M., Larsen, S., Badolo, L., Smith, G. P., Jeggo, R., Jensen, P. H., Sotty, F., Christensen, K. V. & Thougaard, A., 15 Feb 2018, In: Toxicology. 395, p. 15-22 8 p.

    Research output: Contribution to journal › Journal article › peer-review

ID: 201649802